Puma Biotechnology, Inc. (PBYI)
8.26
-0.14
(-1.61%)
USD |
NASDAQ |
Nov 10, 09:50
Puma Biotechnology Price to Book Value : 3.047 for Nov. 10, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 09, 2026 | 3.096 |
| November 06, 2026 | 3.043 |
| November 05, 2026 | 3.604 |
| November 04, 2026 | 3.943 |
| November 03, 2026 | 3.770 |
| November 02, 2026 | 3.755 |
| October 30, 2026 | 3.851 |
| October 29, 2026 | 3.888 |
| October 28, 2026 | 3.917 |
| October 27, 2026 | 4.028 |
| October 26, 2026 | 4.002 |
| October 23, 2026 | 4.065 |
| October 22, 2026 | 4.153 |
| October 21, 2026 | 4.020 |
| October 20, 2026 | 3.969 |
| October 19, 2026 | 3.766 |
| October 16, 2026 | 3.626 |
| October 15, 2026 | 3.880 |
| October 14, 2026 | 3.762 |
| October 13, 2026 | 3.733 |
| October 12, 2026 | 3.796 |
| October 09, 2026 | 3.796 |
| October 08, 2026 | 3.678 |
| October 07, 2026 | 3.618 |
| October 06, 2026 | 3.504 |
| Date | Value |
|---|---|
| October 05, 2026 | 3.567 |
| October 02, 2026 | 3.508 |
| October 01, 2026 | 3.630 |
| September 30, 2026 | 3.663 |
| September 29, 2026 | 3.607 |
| September 28, 2026 | 3.622 |
| September 25, 2026 | 3.604 |
| September 24, 2026 | 3.622 |
| September 23, 2026 | 3.423 |
| September 22, 2026 | 3.622 |
| September 21, 2026 | 3.537 |
| September 18, 2026 | 3.541 |
| September 17, 2026 | 3.512 |
| September 16, 2026 | 3.464 |
| September 15, 2026 | 3.412 |
| September 14, 2026 | 3.371 |
| September 11, 2026 | 3.364 |
| September 10, 2026 | 3.382 |
| September 09, 2026 | 3.338 |
| September 08, 2026 | 3.464 |
| September 04, 2026 | 3.523 |
| September 03, 2026 | 3.471 |
| September 02, 2026 | 3.574 |
| September 01, 2026 | 3.449 |
| August 31, 2026 | 3.360 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Olema Pharmaceuticals, Inc. | 1.466 |
| Anika Therapeutics, Inc. | 1.388 |
| ACADIA Pharmaceuticals, Inc. | 2.179 |
| Alnylam Pharmaceuticals, Inc. | 5.797 |
| Savara, Inc. | 7.192 |
Price to Book Value Related Metrics
| PE Ratio | 18.13 |
| PS Ratio | 1.853 |
| Price | 8.26 |
| Earnings Yield | 5.52% |
| Market Cap | 422.11M |
| Operating PE Ratio | 16.42 |